Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005918 · ClinicalTrials.gov registry record · Phase 3
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
A Phase 3 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 3
- Development phase
- 730
- Enrollment target
NCT00005918: Completed Phase 3 study, sponsored by Bristol-Myers Squibb.
NCT00005918 is a Phase 3 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 730 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005918, a Phase 3 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 730 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and effectiveness of 2 forms of stavudine (d4T). One form is taken once a day (extended release) and the other form is taken twice a day (immediate release).
Interventions
- DRUG Lamivudine
- DRUG Efavirenz
- DRUG Stavudine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 730 participants |
| Start Date | 2000-06 |
| Est. Completion | 2002-04 |
| Phase | Phase 3 |
What the finished NCT00005918 record still lists
NCT00005918 is an interventional study that assigns participants to a tested intervention. The registered 730 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Lamivudine is the first listed.
NCT00005918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005918 about?
NCT00005918 is a clinical study titled "Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients". The purpose of this study is to compare the safety and effectiveness of 2 forms of stavudine (d4T). One form is taken once a day (extended release) and the other form is taken twice a day (immediate release).
What is the current status of trial NCT00005918?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 730 participants. The study started on 2000-06. Estimated completion is 2002-04.
What interventions are being tested in trial NCT00005918?
The interventions under investigation include: Lamivudine (DRUG), Efavirenz (DRUG), Stavudine (DRUG).
Who is sponsoring clinical trial NCT00005918?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00005918's enrollment target sits among peer trials
730 489th of 2000 higher than 1,512 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03232918 · 730 participants · Phase 4
Oxytocin and Fetal Heart Rate Changes
- NCT05548283 · 730 participants · Phase 4
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- NCT07312162 · 730 participants
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
- NCT05065216 · 728 participants · Phase 2
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia